Literature DB >> 29697293

Benzothiazole analogs as potential anti-TB agents: computational input and molecular dynamics.

Katharigatta N Venugopala1,2, Mohammed A Khedr1,3, Melendhran Pillay4, Susanta K Nayak5, Sandeep Chandrashekharappa6, Bandar E Aldhubiab1, Sree Harsha1, Mahesh Attimard1, Bharti Odhav2.   

Abstract

Biotin is very important for the survival of Mycobacterium tuberculosis. 7,8-Diamino pelargonic acid aminotransaminase (DAPA) is a transaminase enzyme involved in the biosynthesis of biotin. The benzothiazole title compounds were investigated for their in vitro anti-tubercular activity against two tubercular strains: H37Rv (ATCC 25,177) and MDR-MTB (multidrug-resistant M. tuberculosis, resistant to isoniazid, rifampicin, and ethambutol) by an agar incorporation method. The possible binding mode and predicted affinity were computed using a molecular docking study. Among the synthesized compounds in the series, the title compound {2-(benzo[d]thiazol-2-yl-methoxy)-5-fluorophenyl}-(4-chlorophenyl)-methanone was found to exhibit significant activity with minimum inhibitory concentrations of 1 μg/mL and 2 μg/mL against H37Rv and MDR-MTB, respectively; this compound showed the highest binding affinity (-24.75 kcal/mol) as well.

Entities:  

Keywords:  ; Benzothiazole; DAPA: 7,8-diamino pelargonic acid aminotransferase; H37Rv; MDR-MTB; MDR-MTB: multidrug-resistant strains of ; MIC: minimum inhibitory concentration; PLP: Pyridoxal phosphate; SAM: S-adenosylmethionine; XDR-MTB: extensively drug-resistant ; minimum inhibitory concentration; single crystal X-ray studies

Mesh:

Substances:

Year:  2018        PMID: 29697293     DOI: 10.1080/07391102.2018.1470035

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  7 in total

Review 1.  Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents.

Authors:  Mohammed F Arshad; Aftab Alam; Abdullah Ayed Alshammari; Mohammed Bader Alhazza; Ibrahim Mohammed Alzimam; Md Anish Alam; Gulam Mustafa; Md Salahuddin Ansari; Abdulelah M Alotaibi; Abdullah A Alotaibi; Suresh Kumar; Syed Mohammed Basheeruddin Asdaq; Mohd Imran; Pran Kishore Deb; Katharigatta N Venugopala; Shahamah Jomah
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

2.  Synthesis and Evaluation of Marine Natural Product-Inspired Meroterpenoids with Selective Activity toward Dormant Mycobacterium tuberculosis.

Authors:  Anshupriya Si; Alexander D Landgraf; Sandra Geden; Steven J Sucheck; Kyle H Rohde
Journal:  ACS Omega       Date:  2022-06-27

3.  New Quinoline-Urea-Benzothiazole Hybrids as Promising Antitubercular Agents: Synthesis, In Vitro Antitubercular Activity, Cytotoxicity Studies, and In Silico ADME Profiling.

Authors:  Rashmika Moodley; Chakes Mashaba; Goitsemodimo H Rakodi; Nomagugu B Ncube; Mabuatsela V Maphoru; Mohammed O Balogun; Audrey Jordan; Digby F Warner; Rene Khan; Matshawandile Tukulula
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-05

4.  Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification.

Authors:  Katharigatta N Venugopala; Christophe Tratrat; Melendhran Pillay; Fawzi M Mahomoodally; Subhrajyoti Bhandary; Deepak Chopra; Mohamed A Morsy; Michelyne Haroun; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Rashmi Venugopala; Sandeep Chandrashekharappa; Osama I Alwassil; Bharti Odhav
Journal:  Antibiotics (Basel)       Date:  2019-12-03

5.  A Novel Class of Potent Anti-Tyrosinase Compounds with Antioxidant Activity, 2-(Substituted phenyl)-5-(trifluoromethyl)benzo[d]thiazoles: In Vitro and In Silico Insights.

Authors:  YeJi Hwang; Jieun Lee; Hee Jin Jung; Sultan Ullah; Jeongin Ko; Yeongmu Jeong; Yu Jung Park; Min Kyung Kang; Hwayoung Yun; Min-Soo Kim; Pusoon Chun; Hae Young Chung; Hyung Ryong Moon
Journal:  Antioxidants (Basel)       Date:  2022-07-15

6.  Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.

Authors:  Katharigatta N Venugopala; Sandeep Chandrashekharappa; Pran Kishore Deb; Christophe Tratrat; Melendhran Pillay; Deepak Chopra; Nizar A Al-Shar'i; Wafa Hourani; Lina A Dahabiyeh; Pobitra Borah; Rahul D Nagdeve; Susanta K Nayak; Basavaraj Padmashali; Mohamed A Morsy; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Michelyne Haroun; Sheena Shashikanth; Viresh Mohanlall; Raghuprasad Mailavaram
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

7.  Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives.

Authors:  Katharigatta N Venugopala; Sandeep Chandrashekharappa; Christophe Tratrat; Pran Kishore Deb; Rahul D Nagdeve; Susanta K Nayak; Mohamed A Morsy; Pobitra Borah; Fawzi M Mahomoodally; Raghu Prasad Mailavaram; Mahesh Attimarad; Bandar E Aldhubiab; Nagaraja Sreeharsha; Anroop B Nair; Osama I Alwassil; Michelyne Haroun; Viresh Mohanlall; Pottathil Shinu; Rashmi Venugopala; Mahmoud Kandeel; Belakatte P Nandeshwarappa; Yasmine F Ibrahim
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.